An Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma.
Phase of Trial: Phase I/II
Latest Information Update: 19 Mar 2018
At a glance
- Drugs Hormones; Perifosine; Trastuzumab
- Indications Multiple myeloma; Solid tumours
- Focus Adverse reactions
- Sponsors AEterna Zentaris Inc; AOI Pharmaceuticals; Keryx Biopharmaceuticals
- 06 Mar 2018 Status changed from active, no longer recruiting to completed.
- 25 May 2012 Planned End Date changed from 1 Dec 2011 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 25 May 2012 Company added in association field as reported by ClinicalTrials.gov.